17
total announcements
512063.BO · 15 min delayed
Wardwizard Healthcare Ltd
Wardwizard Healthcare Ltd has submitted a certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, confirming the dematerialization of securities for the quarter ended September 2026.
Wardwizard Healthcare Ltd
Wardwizard Healthcare Ltd has announced the voting results of its 42nd Annual General Meeting (AGM), with all resolutions passed with 100% approval from promoters and 89.99% approval from public shareholders. The company has also appointed M/S. MGSA & Company as its statutory auditor for a term of five consecutive years.
Wardwizard Healthcare Ltd
Wardwizard Healthcare Ltd held its 42nd Annual General Meeting (AGM) on September 30, 2026, through video conferencing. The meeting was attended by 9 members, and the requisite quorum was present. The company secretary explained the procedural and technical aspects of the meeting and informed the members about the remote e-voting facility. The resolutions set forth in the notice were deemed to be passed subject to the receipt of requisite number of votes.
Wardwizard Healthcare Ltd
Wardwizard Healthcare Ltd has announced the closure of its trading window from October 1, 2026, for all promoters, directors, and designated persons, and their immediate relatives, until 48 hours after the declaration of unaudited standalone financial results for the second quarter and half year ended September 30, 2026.
Wardwizard Healthcare Ltd
Wardwizard Healthcare Ltd has issued a corrigendum to its notice of 42nd Annual General Meeting, correcting the date and time of the meeting. The company has also disclosed a proposed investment of ₹80,000,000 in a subsidiary company.
Wardwizard Healthcare Ltd
Wardwizard Healthcare Ltd has published a newspaper advertisement regarding the 42nd Annual General Meeting (AGM) to be held on September 30, 2026, through video conferencing. The advertisement was published in the Financial Express and Dainik Pratahkal newspapers on September 1, 2026. The company has also made the information available on its website.
Wardwizard Healthcare Ltd
Wardwizard Healthcare Ltd has announced the appointment of two new directors, Ms. Sathi Kundu and Mr. Yuvraj Priyadarshi, to its board of directors. Ms. Kundu is appointed as an Additional Independent Woman Director, while Mr. Priyadarshi is designated as a Whole-time Director.
Wardwizard Healthcare Ltd
Wardwizard Healthcare Ltd has issued fully convertible warrants to 18 entities, including promoters and non-promoters, on a private placement basis. The warrants are convertible into equity shares at a price of ₹10 per warrant, with a total amount of ₹12,50,00,000.
Wardwizard Healthcare Ltd
Wardwizard Healthcare Ltd has increased its authorized capital from Rs. 7.5 crores to Rs. 25 crores by issuing 2.5 crores new equity shares of Rs. 10 each.
Wardwizard Healthcare Ltd
Wardwizard Healthcare Ltd has increased its authorized share capital from ₹7,50,00,000 to ₹25,00,00,000, and issued warrants on a preferential basis to its promoters and non-promoter groups. The company has also approved the appointment of Ms. Sathi Kundu as an independent director and Mr. Yuvraj Priyadarshi as a whole-time director.
Wardwizard Healthcare Ltd
Wardwizard Healthcare Ltd has closed its trading window for designated persons and their immediate relatives from August 24, 2026, until 48 hours after the board meeting on August 31, 2026, to consider fund raising and other matters.
Wardwizard Healthcare Ltd
Wardwizard Healthcare Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 31/08/2026 to consider and approve proposal for raising further capital, increase in authorized share capital, and consequential alteration of the capital clause.
Wardwizard Healthcare Ltd
Wardwizard Healthcare Ltd has published its unaudited financial results for the first quarter ended June 30, 2026, in accordance with SEBI regulations. The results are available on the company's website and in the Financial Express, Pratahkal, and other newspapers.
Wardwizard Healthcare Ltd
Wardwizard Healthcare Ltd has announced its unaudited financial results for the first quarter ended June 30, 2026, which have been approved by the Board of Directors. The results are available on the company's website.
Wardwizard Healthcare Ltd
Wardwizard Healthcare Ltd's board of directors met on August 13, 2026, and approved the unaudited financial results for the first quarter and three months ended June 30, 2026. The results will be available on the company's website. The trading window for designated persons will open on August 17, 2026.
Wardwizard Healthcare Ltd
Wardwizard Healthcare Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/08/2026 to consider and approve the Un-audited Standalone Financial Results of the Company for the First quarter ended 30th June, 2026.
Wardwizard Healthcare Ltd
Wardwizard Healthcare Ltd. announced the closure of its trading window for Promoters, Directors, and Designated Persons, effective from July 1, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the declaration of the unaudited standalone financial results for the first quarter and three months ended June 30, 2026. The trading window will reopen 48 hours after the results are published, with the date of the Board Meeting to be intimated separately.